However, the above indicators were improved in COPD diabetic rats injected with SB431542 (an inhibitor of the activin receptor-like kinase [ALK] receptors ALK5, ALK4 and ALK7). The gene discussed is TGFBR1; the disease is chronic obstructive pulmonary disease.